{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:41:03Z","timestamp":1790516463386,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Grant-in-Aid for Research on Hepatitis from the Japanese Agency for Medical Research and Development","award":["JP19fk0210021"],"award-info":[{"award-number":["JP19fk0210021"]}]},{"name":"Grant-in-Aid for Research on Hepatitis from the Japanese Agency for Medical Research and Development","award":["JP20fk0210064"],"award-info":[{"award-number":["JP20fk0210064"]}]},{"name":"Grant-in-Aid for Research on Hepatitis from the Japanese Agency for Medical Research and Development","award":["JP19fk0210021"],"award-info":[{"award-number":["JP19fk0210021"]}]},{"name":"Grant-in-Aid for Research on Hepatitis from the Japanese Agency for Medical Research and Development","award":["JP19fk0210021"],"award-info":[{"award-number":["JP19fk0210021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autophagy, a degradation system, works to maintain cellular homeostasis. However, as the impact of Hepatitis C virus (HCV) infection on hepatocyte autophagy and its effect on HCV replication remain unclear, we examined them. HCV infection suppressed late-stage autophagy and increased Rubicon. siRNA-mediated knockdown of Rubicon promoted autophagy in HCV-infected cells. In Huh-7 cells harbouring the HCV replicon, Rubicon knockdown downregulated the expression of type 1 interferon (IFN)-related genes and upregulated HCV replication. Rubicon overexpression or administration of bafilomycin A1 or chloroquine, an inhibitor of late-stage autophagy, suppressed autophagy and activated the type 1 IFN pathway. On the other hand, Atg7 knockout suppressed early-stage autophagy and did not activate the type 1 IFN pathway. In livers of humanized liver chimeric mice, HCV infection increased Rubicon and enhanced type 1 IFN signalling. Elimination of HCV in the mice reduced the increase in Rubicon due to HCV infection. The expression levels of Rubicon and IFN-stimulated genes in chronic hepatitis C patients were higher than those in non-B, non-C hepatitis patients. HCV infection increased Rubicon and suppressed hepatocyte autophagy, leading to activation of the intracellular immune response. Rubicon induction is involved in HCV replication via activation of the intracellular immune response.<\/jats:p>","DOI":"10.1038\/s41598-020-72294-y","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T21:28:45Z","timestamp":1600378125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Hepatitis C virus enhances Rubicon expression, leading to autophagy inhibition and intracellular innate immune activation"],"prefix":"10.1038","volume":"10","author":[{"given":"Yuto","family":"Shiode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Hikita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadatsugu","family":"Sakane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugo","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Nakabori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Narumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Sakamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tomonaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohide","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"key":"72294_CR1","doi-asserted-by":"publisher","first-page":"17006","DOI":"10.1038\/nrdp.2017.6","volume":"3","author":"MP Manns","year":"2017","unstructured":"Manns, M. P. et al. Hepatitis C virus infection. Nat. Rev. Dis. Primer 3, 17006 (2017).","journal-title":"Nat. Rev. Dis. Primer"},{"key":"72294_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-pathol-012414-040323","volume":"10","author":"MV Lin","year":"2015","unstructured":"Lin, M. V., King, L. Y. & Chung, R. T. Hepatitis C virus-associated cancer. Annu. Rev. Pathol. 10, 345\u2013370 (2015).","journal-title":"Annu. Rev. Pathol."},{"key":"72294_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jhep.2017.09.008","volume":"68","author":"VC Di Maio","year":"2018","unstructured":"Di Maio, V. C. et al. Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?. J. Hepatol. 68, 597\u2013600 (2018).","journal-title":"J. Hepatol."},{"key":"72294_CR4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00535-015-1108-6","volume":"50","author":"Y Kai","year":"2015","unstructured":"Kai, Y. et al. Emergence of hepatitis C virus NS5A L31V plus Y93H variant upon treatment failure of daclatasvir and asunaprevir is relatively resistant to ledipasvir and NS5B polymerase nucleotide inhibitor GS-558093 in human hepatocyte chimeric mice. J. Gastroenterol. 50, 1145\u20131151 (2015).","journal-title":"J. Gastroenterol."},{"key":"72294_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13401","author":"G Suda","year":"2019","unstructured":"Suda, G. et al. Effects of resistance-associated variants in genotype 2 hepatitis C virus on viral replication and susceptibility to antihepatitis C virus drugs. Hepatol. Res. Off. J. Jpn. Soc. Hepatol. https:\/\/doi.org\/10.1111\/hepr.13401 (2019).","journal-title":"Hepatol. Res. Off. J. Jpn. Soc. Hepatol."},{"key":"72294_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/jgh.13809","volume":"33","author":"K Hayashi","year":"2018","unstructured":"Hayashi, K. et al. Comparison of direct sequencing and Invader assay for Y93H mutation and response to interferon-free therapy in hepatitis C virus genotype 1b. J. Gastroenterol. Hepatol. 33, 249\u2013255 (2018).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"72294_CR7","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1101\/gad.1599207","volume":"21","author":"N Mizushima","year":"2007","unstructured":"Mizushima, N. Autophagy: process and function. Genes Dev. 21, 2861\u20132873 (2007).","journal-title":"Genes Dev."},{"key":"72294_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/ncb0910-823","volume":"12","author":"N Mizushima","year":"2010","unstructured":"Mizushima, N. & Levine, B. Autophagy in mammalian development and differentiation. Nat. Cell Biol. 12, 823\u2013830 (2010).","journal-title":"Nat. Cell Biol."},{"key":"72294_CR9","doi-asserted-by":"publisher","first-page":"265353","DOI":"10.1155\/2014\/265353","volume":"2014","author":"T Vescovo","year":"2014","unstructured":"Vescovo, T. et al. Autophagy in HCV infection: keeping fat and inflammation at bay. BioMed Res. Int. 2014, 265353 (2014).","journal-title":"BioMed Res. Int."},{"key":"72294_CR10","doi-asserted-by":"publisher","first-page":"8705","DOI":"10.1128\/JVI.00616-12","volume":"86","author":"S Shrivastava","year":"2012","unstructured":"Shrivastava, S., Bhanja Chowdhury, J., Steele, R., Ray, R. & Ray, R. B. Hepatitis C virus upregulates Beclin1 for induction of autophagy and activates mTOR signaling. J. Virol. 86, 8705\u20138712 (2012).","journal-title":"J. Virol."},{"key":"72294_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1172\/JCI41474","volume":"121","author":"P-Y Ke","year":"2011","unstructured":"Ke, P.-Y. & Chen, S.S.-L. Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro. J. Clin. Investig. 121, 37\u201356 (2011).","journal-title":"J. Clin. Investig."},{"key":"72294_CR12","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1099\/jgv.0.001161","volume":"99","author":"H Mori","year":"2018","unstructured":"Mori, H. et al. Induction of selective autophagy in cells replicating hepatitis C virus genome. J. Gen. Virol. 99, 1643\u20131657 (2018).","journal-title":"J. Gen. Virol."},{"key":"72294_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","volume":"445","author":"I Tanida","year":"2008","unstructured":"Tanida, I., Ueno, T. & Kominami, E. LC3 and Autophagy. Methods Mol. Biol. Clifton NJ 445, 77\u201388 (2008).","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"72294_CR14","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1128\/JVI.79.5.2689-2699.2005","volume":"79","author":"R Sumpter","year":"2005","unstructured":"Sumpter, R. et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase. RIG-I. J. Virol. 79, 2689\u20132699 (2005).","journal-title":"RIG-I. J. Virol."},{"key":"72294_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41467-019-08729-6","volume":"10","author":"S Nakamura","year":"2019","unstructured":"Nakamura, S. et al. Suppression of autophagic activity by Rubicon is a signature of aging. Nat. Commun. 10, 847 (2019).","journal-title":"Nat. Commun."},{"key":"72294_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/cmi.2017.1","volume":"14","author":"Y Wan","year":"2017","unstructured":"Wan, Y. et al. Inducible Rubicon facilitates viral replication by antagonizing interferon production. Cell. Mol. Immunol. 14, 607\u2013620 (2017).","journal-title":"Cell. Mol. Immunol."},{"key":"72294_CR17","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.jhep.2013.07.033","volume":"59","author":"P Metz","year":"2013","unstructured":"Metz, P., Reuter, A., Bender, S. & Bartenschlager, R. Interferon-stimulated genes and their role in controlling hepatitis C virus. J. Hepatol. 59, 1331\u20131341 (2013).","journal-title":"J. Hepatol."},{"key":"72294_CR18","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1365-2893.2006.00732.x","volume":"13","author":"Y Itsui","year":"2006","unstructured":"Itsui, Y. et al. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J. Viral Hepat. 13, 690\u2013700 (2006).","journal-title":"J. Viral Hepat."},{"issue":"185","key":"72294_CR19","first-page":"4311","volume":"1950","author":"M-J Kim","year":"2010","unstructured":"Kim, M.-J. & Yoo, J.-Y. Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A. J. Immunol. Baltim. Md 1950(185), 4311\u20134318 (2010).","journal-title":"J. Immunol. Baltim. Md"},{"key":"72294_CR20","doi-asserted-by":"publisher","first-page":"12881","DOI":"10.1128\/JVI.05633-11","volume":"85","author":"A Raychoudhuri","year":"2011","unstructured":"Raychoudhuri, A. et al. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J. Virol. 85, 12881\u201312889 (2011).","journal-title":"J. Virol."},{"key":"72294_CR21","doi-asserted-by":"publisher","first-page":"e1003056","DOI":"10.1371\/journal.ppat.1003056","volume":"8","author":"I Romero-Brey","year":"2012","unstructured":"Romero-Brey, I. et al. Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLoS Pathog. 8, e1003056 (2012).","journal-title":"PLoS Pathog."},{"key":"72294_CR22","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1099\/vir.0.022186-0","volume":"91","author":"P Ferraris","year":"2010","unstructured":"Ferraris, P., Blanchard, E. & Roingeard, P. Ultrastructural and biochemical analyses of hepatitis C virus-associated host cell membranes. J. Gen. Virol. 91, 2230\u20132237 (2010).","journal-title":"J. Gen. Virol."},{"key":"72294_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep40351","volume":"7","author":"AM Fahmy","year":"2017","unstructured":"Fahmy, A. M. & Labont\u00e9, P. The autophagy elongation complex (ATG5-12\/16L1) positively regulates HCV replication and is required for wild-type membranous web formation. Sci. Rep. 7, 1\u201313 (2017).","journal-title":"Sci. Rep."},{"key":"72294_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/(SICI)1096-9071(199910)59:2<141::AID-JMV3>3.0.CO;2-5","volume":"59","author":"H Fujie","year":"1999","unstructured":"Fujie, H. et al. Steatosis and intrahepatic hepatitis C virus in chronic hepatitis. J. Med. Virol. 59, 141\u2013145 (1999).","journal-title":"J. Med. Virol."},{"key":"72294_CR25","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/hep.1840150403","volume":"15","author":"N Bach","year":"1992","unstructured":"Bach, N., Thung, S. N. & Schaffner, F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatol. Baltim. Md 15, 572\u2013577 (1992).","journal-title":"Hepatol. Baltim. Md"},{"key":"72294_CR26","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1073\/pnas.0911373107","volume":"107","author":"D Sir","year":"2010","unstructured":"Sir, D. et al. The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication. Proc. Natl. Acad. Sci. USA 107, 4383\u20134388 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72294_CR27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/hep4.1056","volume":"1","author":"RJ Schulze","year":"2017","unstructured":"Schulze, R. J., Dri\u017eyt\u0117, K., Casey, C. A. & McNiven, M. A. Hepatic lipophagy: new insights into autophagic catabolism of lipid droplets in the liver. Hepatol. Commun. 1, 359\u2013369 (2017).","journal-title":"Hepatol. Commun."},{"key":"72294_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28820","author":"S Tanaka","year":"2016","unstructured":"Tanaka, S. et al. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice. Hepatol. Baltim. Md https:\/\/doi.org\/10.1002\/hep.28820 (2016).","journal-title":"Hepatol. Baltim. Md"},{"key":"72294_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1126\/science.285.5424.110","volume":"285","author":"V Lohmann","year":"1999","unstructured":"Lohmann, V. et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110\u2013113 (1999).","journal-title":"Science"},{"key":"72294_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"B Levine","year":"2008","unstructured":"Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell 132, 27\u201342 (2008).","journal-title":"Cell"},{"key":"72294_CR31","unstructured":"The reconstituted \u2018humanized liver\u2019 in TK-NOG mice is mature and functional. - PubMed - NCBI. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21238430."},{"key":"72294_CR32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00535-018-01541-x","volume":"54","author":"A Doi","year":"2019","unstructured":"Doi, A. et al. Combinations of two drugs among NS3\/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver mice. J. Gastroenterol. 54, 449\u2013458 (2019).","journal-title":"J. Gastroenterol."},{"key":"72294_CR33","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1021\/pr700658q","volume":"7","author":"T Masuda","year":"2008","unstructured":"Masuda, T., Tomita, M. & Ishihama, Y. Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis. J. Proteome Res. 7, 731\u2013740 (2008).","journal-title":"J. Proteome Res."},{"key":"72294_CR34","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nprot.2007.261","volume":"2","author":"J Rappsilber","year":"2007","unstructured":"Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896\u20131906 (2007).","journal-title":"Nat. Protoc."},{"key":"72294_CR35","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372 (2008).","journal-title":"Nat. Biotechnol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72294-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72294-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72294-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T18:46:27Z","timestamp":1670352387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72294-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72294"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72294-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"11 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15290"}}